Search alternatives:
point decrease » point increase (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 point » _ point (Expand Search)
point decrease » point increase (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 point » _ point (Expand Search)
-
40081
-
40082
-
40083
-
40084
WTA stimulates in vitro T-cell activation by a MHC-II dependent mechanism.
Published 2010“…Shown are means ± SEM. n = 5. C). WTA induced T-cell proliferation only with Raji cells as APCs but not when APCs were from the MHC II negative cell line RJ2.5.5. …”
-
40085
-
40086
Modified Downs and Black (1998) [36] scores.
Published 2023“…Five studies demonstrated post-exercise changes in sweat rates and four studies showed decreases in mean skin temperature. …”
-
40087
hMSCs reduces proliferation of stimulated lymphocytes in a contact-independent manner.
Published 2014“…<p>(A–B) A significant proliferation reduction of PHA stimulated lymphocytes (CD3) (38.58±12.39%) assessed by expression of KI-67 was observed in presence of hMSCs (CD3: hMSC) (24.39±12.39%), the same was observed when absolute number KI-67 expressing cells was evaluated decreasing from (3.0×10<sup>5</sup>±1.3×10<sup>5</sup>) up to (1.7×10<sup>5</sup>±0.9×10<sup>5</sup>) (n = 8). …”
-
40088
Image_1_Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation?.pdf
Published 2022“…Background<p>The impact of nirmatrelvir/ritonavir treatment on shedding of viable virus in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear.</p>Methods<p>A prospective cohort study evaluating mildly ill COVID-19 patients was conducted. …”
-
40089
-
40090
Autophagy mediates the inhibitory effect of CB2R on NLRP3 inflammasome initiation and activation stimulated with LPS/DSS <i>in vitro</i>.
Published 2016“…<p>(A) The quantitative expression of mRNA in RAW264.7 cells after transfection with control siRNA or <i>Atg5</i> siRNAs. n = 6 per group. …”
-
40091
-
40092
-
40093
Representative changes of tumor size and necrosis size with attenuation on first follow-up contrast-enhanced computed tomography (CT) scans in metastatic renal cell carcinoma (RCC)...
Published 2017“…<p>A. Axial CT image before sunitinib therapy showed a 14.5 cm-sized enhancing left renal mass with hilar invasion and presence of venous tumor thrombi. …”
-
40094
DataSheet_1_The Spleen as a Target to Characterize Immunomodulatory Effects of Down-Stream Processed Cyberlindnera jadinii Yeasts in Atlantic Salmon Exposed to a Dietary Soybean Me...
Published 2021“…Finally, we suggest that the spleen is a good candidate to characterize the immunomodulatory effects of functional ingredients in Atlantic salmon. …”
-
40095
DataSheet_2_The Spleen as a Target to Characterize Immunomodulatory Effects of Down-Stream Processed Cyberlindnera jadinii Yeasts in Atlantic Salmon Exposed to a Dietary Soybean Me...
Published 2021“…Finally, we suggest that the spleen is a good candidate to characterize the immunomodulatory effects of functional ingredients in Atlantic salmon. …”
-
40096
Table 2_The effect of treatment with a non-ionic surfactant vesicular formulation of sodium stibogluconate on host immune responses and serum metabolites in a murine model of Leish...
Published 2025“…</p>Methods<p>BALB/c mice infected with L. donovani were divided into cured and non-cured groups based on treatment with a non-ionic surfactant vesicle formulation of sodium stibogluconate (300 mg Sb<sup>v</sup>/kg, SSG-NIV) or PBS vehicle control. …”
-
40097
Table 1_The effect of treatment with a non-ionic surfactant vesicular formulation of sodium stibogluconate on host immune responses and serum metabolites in a murine model of Leish...
Published 2025“…</p>Methods<p>BALB/c mice infected with L. donovani were divided into cured and non-cured groups based on treatment with a non-ionic surfactant vesicle formulation of sodium stibogluconate (300 mg Sb<sup>v</sup>/kg, SSG-NIV) or PBS vehicle control. …”
-
40098
-
40099
-
40100
Supplementary Material for: Intentional Weight Loss and Dose Reductions of Antihypertensive Medications: A Retrospective Cohort Study
Published 2013“…<b><i>Results:</i></b> The study cohort consisted of 100 participants, and the mean follow-up period was 15 ± 3.5 months. Significant weight loss (12.2 ± 3.4 kg) and systolic/diastolic blood pressure reductions (9.1/6.3 mm Hg) were observed by study exit. …”